INTERCOS SPA (ICOS.MI) Stock Fundamental Analysis
BIT:ICOS - Euronext Milan - IT0005455875 - Common Stock - Currency: EUR
Overall ICOS gets a fundamental rating of 4 out of 10. We evaluated ICOS against 12 industry peers in the Personal Care Products industry. ICOS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ICOS is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ICOS was profitable.
In the past year ICOS had a positive cash flow from operations.
ICOS had positive earnings in each of the past 5 years.
In the past 5 years ICOS always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.47%, ICOS is doing worse than 66.67% of the companies in the same industry.
Looking at the Return On Equity, with a value of 10.11%, ICOS is doing worse than 66.67% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 11.79%, ICOS is in line with its industry, outperforming 41.67% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ICOS is below the industry average of 12.82%.
The last Return On Invested Capital (11.79%) for ICOS is above the 3 year average (9.12%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.47% | ||
| ROE | 10.11% | ||
| ROIC | 11.79% |
ROA(3y)4.28%
ROA(5y)4.65%
ROE(3y)10.02%
ROE(5y)12.49%
ROIC(3y)9.12%
ROIC(5y)9.57%
1.3 Margins
ICOS's Profit Margin of 4.51% is in line compared to the rest of the industry. ICOS outperforms 41.67% of its industry peers.
ICOS's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 8.72%, ICOS is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
ICOS's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 19.61%, ICOS is not doing good in the industry: 91.67% of the companies in the same industry are doing better.
ICOS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.72% | ||
| PM (TTM) | 4.51% | ||
| GM | 19.61% |
OM growth 3Y5.36%
OM growth 5Y-2.46%
PM growth 3Y-5.79%
PM growth 5Y-5%
GM growth 3Y-0.48%
GM growth 5Y-2.03%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ICOS is creating some value.
The number of shares outstanding for ICOS remains at a similar level compared to 1 year ago.
The number of shares outstanding for ICOS has been increased compared to 5 years ago.
ICOS has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.15 indicates that ICOS is not in any danger for bankruptcy at the moment.
ICOS has a Altman-Z score (3.15) which is in line with its industry peers.
The Debt to FCF ratio of ICOS is 1.25, which is an excellent value as it means it would take ICOS, only 1.25 years of fcf income to pay off all of its debts.
ICOS has a Debt to FCF ratio of 1.25. This is amongst the best in the industry. ICOS outperforms 91.67% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that ICOS is not too dependend on debt financing.
ICOS has a better Debt to Equity ratio (0.10) than 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 1.25 | ||
| Altman-Z | 3.15 |
ROIC/WACC1.5
WACC7.84%
2.3 Liquidity
A Current Ratio of 1.10 indicates that ICOS should not have too much problems paying its short term obligations.
ICOS has a worse Current ratio (1.10) than 66.67% of its industry peers.
ICOS has a Quick Ratio of 1.10. This is a bad value and indicates that ICOS is not financially healthy enough and could expect problems in meeting its short term obligations.
ICOS has a Quick ratio (0.66) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.1 | ||
| Quick Ratio | 0.66 |
3. Growth
3.1 Past
ICOS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.54%.
Measured over the past 5 years, ICOS shows a small growth in Earnings Per Share. The EPS has been growing by 1.17% on average per year.
ICOS shows a small growth in Revenue. In the last year, the Revenue has grown by 4.57%.
The Revenue has been growing slightly by 7.40% on average over the past years.
EPS 1Y (TTM)-12.54%
EPS 3Y9.52%
EPS 5Y1.17%
EPS Q2Q%-28.96%
Revenue 1Y (TTM)4.57%
Revenue growth 3Y17.67%
Revenue growth 5Y7.4%
Sales Q2Q%2.36%
3.2 Future
Based on estimates for the next years, ICOS will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.47% on average per year.
Based on estimates for the next years, ICOS will show a small growth in Revenue. The Revenue will grow by 2.50% on average per year.
EPS Next Y4.64%
EPS Next 2Y9.52%
EPS Next 3Y11.16%
EPS Next 5Y10.47%
Revenue Next Year7.26%
Revenue Next 2Y6.87%
Revenue Next 3Y6.73%
Revenue Next 5Y2.5%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
ICOS is valuated quite expensively with a Price/Earnings ratio of 28.72.
Based on the Price/Earnings ratio, ICOS is valued a bit more expensive than 66.67% of the companies in the same industry.
ICOS is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.22, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 18.60 indicates a rather expensive valuation of ICOS.
The rest of the industry has a similar Price/Forward Earnings ratio as ICOS.
ICOS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 20.86, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.72 | ||
| Fwd PE | 18.6 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ICOS is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
ICOS's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.36 | ||
| EV/EBITDA | 8.95 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)6.19
PEG (5Y)24.65
EPS Next 2Y9.52%
EPS Next 3Y11.16%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.48%, ICOS has a reasonable but not impressive dividend return.
ICOS's Dividend Yield is slightly below the industry average, which is at 2.64.
Compared to the average S&P500 Dividend Yield of 2.44, ICOS is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.48% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
ICOS pays out 42.88% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP42.88%
EPS Next 2Y9.52%
EPS Next 3Y11.16%
BIT:ICOS (5/2/2025, 7:00:00 PM)
13.5
+0.2 (+1.5%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners39.17%
Inst Owner ChangeN/A
Ins Owners32.2%
Ins Owner ChangeN/A
Market Cap1.30B
Analysts85.71
Price Target17.94 (32.89%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.48% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP42.88%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.4%
PT rev (3m)-1.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-8.78%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.72 | ||
| Fwd PE | 18.6 | ||
| P/S | 1.3 | ||
| P/FCF | 30.36 | ||
| P/OCF | 13.67 | ||
| P/B | 2.92 | ||
| P/tB | 5.09 | ||
| EV/EBITDA | 8.95 |
EPS(TTM)0.47
EY3.48%
EPS(NY)0.73
Fwd EY5.38%
FCF(TTM)0.44
FCFY3.29%
OCF(TTM)0.99
OCFY7.32%
SpS10.38
BVpS4.63
TBVpS2.65
PEG (NY)6.19
PEG (5Y)24.65
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.47% | ||
| ROE | 10.11% | ||
| ROCE | 16.85% | ||
| ROIC | 11.79% | ||
| ROICexc | 15.93% | ||
| ROICexgc | 31.75% | ||
| OM | 8.72% | ||
| PM (TTM) | 4.51% | ||
| GM | 19.61% | ||
| FCFM | 4.29% |
ROA(3y)4.28%
ROA(5y)4.65%
ROE(3y)10.02%
ROE(5y)12.49%
ROIC(3y)9.12%
ROIC(5y)9.57%
ROICexc(3y)13.17%
ROICexc(5y)13.68%
ROICexgc(3y)24.59%
ROICexgc(5y)25.8%
ROCE(3y)13.03%
ROCE(5y)13.69%
ROICexcg growth 3Y24.46%
ROICexcg growth 5Y11.44%
ROICexc growth 3Y21.76%
ROICexc growth 5Y5.26%
OM growth 3Y5.36%
OM growth 5Y-2.46%
PM growth 3Y-5.79%
PM growth 5Y-5%
GM growth 3Y-0.48%
GM growth 5Y-2.03%
F-Score5
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 1.25 | ||
| Debt/EBITDA | 0.34 | ||
| Cap/Depr | 112.13% | ||
| Cap/Sales | 5.23% | ||
| Interest Coverage | 18.71 | ||
| Cash Conversion | 71.1% | ||
| Profit Quality | 94.94% | ||
| Current Ratio | 1.1 | ||
| Quick Ratio | 0.66 | ||
| Altman-Z | 3.15 |
F-Score5
WACC7.84%
ROIC/WACC1.5
Cap/Depr(3y)108.68%
Cap/Depr(5y)109.85%
Cap/Sales(3y)5.59%
Cap/Sales(5y)5.96%
Profit Quality(3y)82.87%
Profit Quality(5y)94.39%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.54%
EPS 3Y9.52%
EPS 5Y1.17%
EPS Q2Q%-28.96%
EPS Next Y4.64%
EPS Next 2Y9.52%
EPS Next 3Y11.16%
EPS Next 5Y10.47%
Revenue 1Y (TTM)4.57%
Revenue growth 3Y17.67%
Revenue growth 5Y7.4%
Sales Q2Q%2.36%
Revenue Next Year7.26%
Revenue Next 2Y6.87%
Revenue Next 3Y6.73%
Revenue Next 5Y2.5%
EBIT growth 1Y-7.51%
EBIT growth 3Y23.97%
EBIT growth 5Y4.76%
EBIT Next Year58.29%
EBIT Next 3Y25.3%
EBIT Next 5Y20.32%
FCF growth 1Y4150.5%
FCF growth 3Y-1.18%
FCF growth 5Y1.22%
OCF growth 1Y134.98%
OCF growth 3Y4.1%
OCF growth 5Y4.57%